Miltuan en es it fr

Miltuan Brand names, Miltuan Analogs

Miltuan Brand Names Mixture

  • No information avaliable

Miltuan Chemical_Formula


Miltuan RX_link

No information avaliable

Miltuan fda sheet

Miltuan msds (material safety sheet)

Miltuan Synthesis Reference

No information avaliable

Miltuan Molecular Weight

309.469 g/mol

Miltuan Melting Point

< 25 oC

Miltuan H2O Solubility

Soluble as HCl salt

Miltuan State


Miltuan LogP


Miltuan Dosage Forms

Tablets (oral, 1 mg)

Miltuan Indication

Used for the symptomatic treatment of parkinsonism.

Miltuan Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltuan Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltuan side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltuan Patient Information

Miltuan Organisms Affected

Humans and other mammals